CompletedNot Applicable

Nalbuphine and Flurbiprofen for Oculoplastic Surgery

China330 participantsStarted 2018-01-18

Plain-language summary

The purpose of this study is to evaluate the postoperative pain and discomfort using flurbiprofen axetil or nalbuphine administration after oculoplastic surgery under general anesthesia.

Who can participate

Age range16 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Undergoing oculoplastic surgery * age between 16 and 75 years * American Society of Anesthesiologists (ASA) physical status of I-II Exclusion Criteria: * serious coexisting disease * body mass index (BMI) \<18.5 or \>35 * contraindications or previous adverse reactions to any of the drugs used * females with a positive pregnancy test * patients unable to cooperate

What they're measuring

Pain 24 hours after recovery

Timeframe: 24 hours after recovery

Trial details

NCT IDNCT03422887

SponsorSun Yat-sen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-08-31

View on ClinicalTrials.gov More Surgery trials